News

To inform marketing authorization holders (MAHs) about the current events, the Latvian Medicines Verification Organisation (LZVO) will hold a special seminar on February 22, 2023.

Today, on February 9, it has been 4 years since the authenticity of medicinal products has been verified in the medicines verification system operating in all of Europe, including Latvia, where it is provided by the Latvian Medicines Verification System (LZVS).

Last year, in Latvia's legal medicines supply chain, through pharmacies and healthcare institutions, the residents received only safe prescription medicines and omeprazole, which were verified in the medicines verification system – slightly more than 28 million checked packages reached the population.

The Latvian Medicines Verification Organization (LZVO) in the fourth issue of the Newsletter (January 2023) looks back at the year 2022 – the performance indicators of the LZVS in the 4th quarter of 2022 and the year as whole and highlights the current events of 2023.

Summarizing what was done in 2022 and outlining the plans for 2023, the European Medicines Verification Organisation (EMVO) in cooperation with the National Medicines Verification Organisations has published the EMVS Community Newsletter – 2022 Holiday Bulletin edition. In this bulletin, Inese Erdmane, Chairwoman of the Board at the Latvian Medicines Verification Organisation (LZVO), also talks about this year's achievements.

On November 30, 2022, a General Assembly meeting of stakeholders of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2023 were approved.